LTR Pharma Ltd Cash Flow Conversion Efficiency

Latest as of December 2024: -0.070x

LTR Pharma Ltd cash flow conversion efficiency. Based on the latest financial reports, LTR Pharma Ltd (LTP) has a cash flow conversion efficiency ratio of -0.070x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.39 Million ≈ $-1.69 Million USD) by net assets (AU$34.30 Million ≈ $24.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of LTR Pharma Ltd (2022–2024)

Cash flow conversion efficiency of LTR Pharma Ltd from 2022 to 2024. This chart illustrates how LTR Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View LTP stock price for real-time trading data and today's change.

LTR Pharma Ltd Cash Flow Conversion Ratio Explained

LTR Pharma Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

LTR Pharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of LTR Pharma Ltd ranked by their cash flow conversion efficiency. Also see LTR Pharma Ltd (LTP) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Arrienda Rental Properties SOCIMI SA MC:YARP	0.050x
Aztek Teknoloji Urunleri Ticaret A.S. IS:AZTEK	-0.167x
Duran-Dogan Basim ve Ambalaj Sanayi AS IS:DURDO	0.120x
Conexeu Sciences Inc. Common Stock NASDAQ:CNXU	-0.251x
ZenaTech Inc. NASDAQ:ZENA	-0.230x
Evermore Chemical Industry Co Ltd TW:1735	-0.009x
DP POLAND PLC F:2OP	N/A
Optex Systems Holdings, Inc. Common Stock NASDAQ:OPXS	0.084x

Annual Cash Flow Conversion Efficiency for LTR Pharma Ltd (2022–2024)

The table below shows the annual cash flow conversion efficiency of LTR Pharma Ltd from 2022 to 2024. Review LTR Pharma Ltd leverage flexibility ratio to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-06-30	AU$2.94 Million ≈ $2.08 Million	AU$-5.09 Million ≈ $-3.60 Million	-1.732x	-133.74%
2023-06-30	AU$2.07 Million ≈ $1.47 Million	AU$-1.54 Million ≈ $-1.09 Million	-0.741x	-130.74%
2022-06-30	AU$1.77 Million ≈ $1.25 Million	AU$-568.18K ≈ $-402.02K	-0.321x	--

About LTR Pharma Ltd

AU:LTP Australia Biotechnology

Market Cap

$60.45 Million

AU$85.44 Million AUD

Market Cap Rank

#20981 Global

#707 in Australia

Share Price

AU$0.47

Change (1 day)

+4.44%

52-Week Range

AU$0.36 - AU$0.72

All Time High

AU$2.06